文献速递眼底病与葡萄膜炎

患者对SARS-CoV-2暴露风险的感知及其与眼科诊疗连续性的关联

Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care.
PubMed 文献 · JAMA Ophthalmol · 2021-01-01

这项调查研究纳入1004名符合条件患者中的348名参与调查,来自两家三级眼科中心,均为渗出性年龄相关性黄斑变性(AMD)或糖尿病视网膜病变(DR)且曾接受玻璃体腔注射者。结果显示,22%患者失访;对门诊暴露风险的担忧与失访几率增加相关(OR 3.9,95%CI 1.8-8.4),DR诊断(vs AMD)亦与失访增加相关(OR 8.130,95%CI 3.367-20.408)。

要点

  • 22%患者在疫情期间失访,47%对错过治疗导致视力丧失非常或中度担忧。
  • 对门诊暴露SARS-CoV-2的担忧与失访几率增加约4倍相关(OR 3.9)。
  • DR诊断(vs AMD)与失访几率增加相关(OR 8.130)。

核心结论

  • 对SARS-CoV-2暴露的恐惧与患者失访几率增加约4倍相关,支持清晰传达感染控制措施的重要性。

研究设计与样本

  • 调查研究,包含2020年4-5月设计的非验证性电话调查及2020年5月22日至8月18日同步进行的回顾性病历审查。
  • 参与者来自两家三级眼科中心(Emory Eye Center和W.K. Kellogg Eye Center),为2020年1月6日至3月13日接受玻璃体腔注射且计划在2020年3月13日至5月6日接受第二次注射的渗出性AMD或DR患者的随机样本。
  • 1004名 eligible 患者中423名(42%)成功联系,348名(82%)同意参与;参与者平均(SD)年龄75(12)岁,195名女性(56%),287名白人(82%)。

主要发现

  • 受访者平均(SD)有2.7(1.1)种与重症COVID-19相关的合并症,77名(22%)认识COVID-19患者。
  • 163名(47%)对疫情期间错过治疗导致视力丧失非常或中度担忧;208名(60%)认为在眼科诊所暴露SARS-CoV-2极不可能或不太可能,49名(14%)认为极可能或可能。
  • 对诊所就诊期间COVID-19暴露的担忧(OR 3.9;95%CI 1.8-8.4)和DR诊断(vs AMD)(OR 8.130;95%CI 3.367-20.408)与失访可能性增加相关。

关键数值与推荐

  • 对COVID-19暴露的担忧与失访的OR为3.9(95%CI 1.8-8.4)。
  • DR诊断(vs AMD)与失访的OR为8.130(95%CI 3.367-20.408)。

临床怎么用

  • 对高视力丧失风险患者,应清晰传达感染控制措施以减轻对暴露的担忧。
  • 关注DR患者及对暴露担忧者,可能有助于减少失访。

局限性

  • 使用非验证性电话调查。
  • 仅42% eligible患者成功联系,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient perceptions regarding the risks of obtaining in-person ophthalmic care during the coronavirus disease 2019 (COVID-19) pandemic may affect adherence to recommended treatment plans and influence visual outcomes. A deeper understanding of patient perspectives will inform strategies to optimize adherence with vision-preserving therapies. OBJECTIVE: To evaluate perceptions of COVID-19 exposure risk and their association with appointment attendance among patients at high risk of both reversible and irreversible vision loss from lapses in care. DESIGN, SETTING, AND PARTICIPANTS: This survey study included a nonvalidated telephone survey designed in April and May of 2020 and a retrospective medical record review conducted in parallel with survey administration from May 22 to August 18, 2020. Participants were recruited from 2 tertiary eye care centers (Emory Eye Center in Atlanta, Georgia, and W.K. Kellogg Eye Center in Ann Arbor, Michigan). The study included a random sample of patients with diagnoses of exudative age-related macular degeneration (AMD) or diabetic retinopathy (DR) who received an intravitreal injection between January 6 and March 13, 2020, and were scheduled for a second injection between March 13 and May 6, 2020. MAIN OUTCOMES AND MEASURES: Association between perceptions regarding COVID-19 risks and loss to follow-up. RESULTS: Of 1004 eligible patients, 423 (42%) were successfully contacted, and 348 (82%) agreed to participate (participants' mean [SD] age, 75 [12] years; 195 women [56%]; 287 White [82%] patients). Respondents had a mean (SD) of 2.7 (1.1) comorbidities associated with severe COVID-19, and 77 (22%) knew someone with COVID-19. Of all respondents, 163 (47%) were very concerned or moderately concerned about vision loss from missed treatments during the pandemic. Although 208 (60%) believed the COVID-19 virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exposure at the eye clinic was extremely unlikely or unlikely, 49 (14%) believed it was extremely likely or likely. Seventy-eight participants (22%) were lost to follow-up. Concern regarding COVID-19 exposure during clinic visits (odds ratio [OR], 3.9; 95% CI, 1.8-8.4) and diagnosis of DR (vs AMD) (OR, 8.130; 95% CI, 3.367-20.408) were associated with an increase in likelihood of loss to follow-up. CONCLUSIONS AND RELEVANCE: Among patients at high risk for vision loss from lapses in care, many expressed concerns regarding the effect of the pandemic on their ability to receive timely care. Survey results suggest that fear of SARS-CoV-2 exposure was associated with a roughly 4-fold increase in the odds of patient loss to follow-up. These results support the potential importance of clearly conveying infection-control measures.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lindeke-Myers A, Zhao PYC, Meyer BI, et al. Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care. JAMA Ophthalmol. 2021. PMID: 33704358. doi:10.1001/jamaophthalmol.2021.0114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。